Clinical Development Platforms Product Provider Compendium 2022
Provider Compendium Report

18 Aug 2022
by Nitish Mittal, Chunky Satija, Nisarg Shah, Anik Dutta, Madhur Kakade

Clinical development platforms typically evolve with technology advances and scientific breakthroughs. Notably, the COVID-19 pandemic accelerated the adoption of digital technologies, data science, analytics, and automation tools, enabling remote services and preserving the continuity of care.

A unified clinical development platform with improved data architecture and analytics capabilities can accelerate the drug development process and enrich the experience for sponsors, patients, and physicians. In recent years, the industry has pivoted from questioning the existence of end-to-end platforms to creating a near-term vision for adopting such platforms.

Everest Group’s Clinical Development Platforms Products PEAK Matrix® Assessment 2022 looks at the vendor landscape of clinical development platforms and presents in-depth analysis and insights on these platforms. We assess the capabilities of 22 clinical development platform vendors and map them on the Everest Group PEAK Matrix®, a composite index of distinct metrics related to a vendor’s capability and market impact.

Scope

Industry: life sciences

Geography: global

Contents

This report features 22 clinical development product vendors’ profiles and includes:

  • Assessment of the product vendors on several capability and market success-related dimensions
  • Detailed profiles of each product vendor, featuring case studies and recent developments
  • Strengths and limitations of each vendor
  • Buying sourcing considerations

Membership(s)

Life Sciences Information Technology

Sourcing and Vendor Management

 

Page Count: 205